Riccardo Sangermano, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
ATP-Binding Cassette Transporters | 9 | 2020 | 563 | 2.010 |
Why?
|
Retinal Degeneration | 3 | 2023 | 413 | 1.370 |
Why?
|
Macular Degeneration | 7 | 2022 | 1007 | 1.090 |
Why?
|
RNA Splice Sites | 4 | 2020 | 211 | 0.960 |
Why?
|
Night Blindness | 1 | 2022 | 56 | 0.830 |
Why?
|
Lactoferrin | 2 | 2020 | 100 | 0.800 |
Why?
|
Kidney Diseases, Cystic | 1 | 2023 | 183 | 0.750 |
Why?
|
Eye Abnormalities | 1 | 2023 | 242 | 0.710 |
Why?
|
Tooth Discoloration | 1 | 2019 | 15 | 0.690 |
Why?
|
Oligonucleotides, Antisense | 3 | 2019 | 461 | 0.680 |
Why?
|
Iron Metabolism Disorders | 1 | 2019 | 24 | 0.670 |
Why?
|
Pedigree | 12 | 2024 | 4542 | 0.640 |
Why?
|
Exons | 6 | 2020 | 2391 | 0.630 |
Why?
|
RNA Splicing | 3 | 2020 | 918 | 0.560 |
Why?
|
RNA Precursors | 1 | 2017 | 212 | 0.540 |
Why?
|
Dental Caries | 1 | 2019 | 427 | 0.500 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2018 | 203 | 0.500 |
Why?
|
Abnormalities, Multiple | 1 | 2023 | 1423 | 0.500 |
Why?
|
Protein Isoforms | 1 | 2019 | 1699 | 0.450 |
Why?
|
Anti-Infective Agents | 1 | 2019 | 983 | 0.390 |
Why?
|
Alternative Splicing | 1 | 2016 | 1093 | 0.360 |
Why?
|
Retinal Dystrophies | 2 | 2022 | 65 | 0.340 |
Why?
|
Introns | 4 | 2019 | 981 | 0.310 |
Why?
|
Retinitis Pigmentosa | 2 | 2024 | 397 | 0.270 |
Why?
|
Gastritis, Hypertrophic | 2 | 2017 | 9 | 0.250 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2022 | 27 | 0.210 |
Why?
|
Stem Cells | 1 | 2016 | 3524 | 0.210 |
Why?
|
RNA, Messenger | 2 | 2018 | 12794 | 0.200 |
Why?
|
INDEL Mutation | 1 | 2022 | 266 | 0.190 |
Why?
|
HEK293 Cells | 4 | 2020 | 4281 | 0.190 |
Why?
|
Mutation | 7 | 2023 | 30053 | 0.190 |
Why?
|
Retinal Diseases | 2 | 2024 | 705 | 0.190 |
Why?
|
Frameshift Mutation | 1 | 2022 | 392 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15936 | 0.170 |
Why?
|
Electroretinography | 3 | 2018 | 525 | 0.170 |
Why?
|
Haplotypes | 3 | 2024 | 2713 | 0.160 |
Why?
|
Blindness | 1 | 2022 | 584 | 0.160 |
Why?
|
Dental Plaque | 1 | 2019 | 209 | 0.150 |
Why?
|
Mouth | 1 | 2020 | 381 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2024 | 3639 | 0.140 |
Why?
|
Genes, Recessive | 1 | 2019 | 623 | 0.130 |
Why?
|
Stomach Diseases | 1 | 2017 | 134 | 0.130 |
Why?
|
Cerebellum | 1 | 2023 | 1501 | 0.120 |
Why?
|
Saliva | 1 | 2019 | 828 | 0.120 |
Why?
|
Fluorescein Angiography | 2 | 2018 | 1059 | 0.110 |
Why?
|
Genetic Markers | 1 | 2020 | 2601 | 0.110 |
Why?
|
Visual Acuity | 3 | 2019 | 2672 | 0.110 |
Why?
|
Transforming Growth Factor alpha | 1 | 2012 | 135 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2017 | 744 | 0.100 |
Why?
|
Retina | 1 | 2023 | 2659 | 0.100 |
Why?
|
Genome, Human | 2 | 2024 | 4425 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4111 | 0.090 |
Why?
|
Genes, Dominant | 1 | 2012 | 852 | 0.090 |
Why?
|
Alleles | 4 | 2024 | 6864 | 0.080 |
Why?
|
Visual Fields | 1 | 2016 | 1062 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1035 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4576 | 0.080 |
Why?
|
Stomach | 1 | 2012 | 696 | 0.080 |
Why?
|
Transfection | 1 | 2016 | 5774 | 0.070 |
Why?
|
Humans | 21 | 2024 | 761596 | 0.070 |
Why?
|
Adult | 9 | 2024 | 221210 | 0.070 |
Why?
|
Genetic Variation | 2 | 2020 | 6567 | 0.070 |
Why?
|
Gene Frequency | 3 | 2019 | 3606 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2017 | 2571 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1899 | 0.070 |
Why?
|
Child | 5 | 2024 | 80158 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 2118 | 0.060 |
Why?
|
Male | 14 | 2024 | 360846 | 0.060 |
Why?
|
Young Adult | 4 | 2024 | 59260 | 0.060 |
Why?
|
Fibroblasts | 1 | 2016 | 4142 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2735 | 0.060 |
Why?
|
Female | 14 | 2024 | 392705 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1964 | 0.060 |
Why?
|
Sequence Analysis, DNA | 3 | 2024 | 4740 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1860 | 0.060 |
Why?
|
Phenotype | 4 | 2024 | 16592 | 0.050 |
Why?
|
Computational Biology | 2 | 2024 | 3517 | 0.050 |
Why?
|
Republic of Korea | 1 | 2024 | 590 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7406 | 0.050 |
Why?
|
Genetic Testing | 2 | 2024 | 3537 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 220921 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2024 | 604 | 0.040 |
Why?
|
Homozygote | 1 | 2024 | 1776 | 0.040 |
Why?
|
Dystrophin | 1 | 2020 | 283 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2022 | 569 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 704 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 6032 | 0.040 |
Why?
|
Heterozygote | 1 | 2024 | 2787 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 2018 | 555 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 29890 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1633 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 383 | 0.030 |
Why?
|
Canada | 1 | 2022 | 2122 | 0.030 |
Why?
|
Biofilms | 1 | 2020 | 627 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2024 | 7859 | 0.030 |
Why?
|
Adolescent | 2 | 2024 | 88326 | 0.030 |
Why?
|
Siblings | 1 | 2018 | 825 | 0.030 |
Why?
|
Aged | 4 | 2019 | 169310 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2018 | 2917 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2014 | 411 | 0.020 |
Why?
|
Ubiquitination | 1 | 2017 | 1007 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2017 | 2677 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 732 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3306 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2015 | 1494 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2012 | 604 | 0.020 |
Why?
|
Hyperplasia | 1 | 2012 | 1152 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1668 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 22176 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12441 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42232 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6241 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
Family | 1 | 2012 | 3195 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80647 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18966 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23741 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10774 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54423 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11904 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168475 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41495 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12690 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23447 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17904 | 0.010 |
Why?
|